Both Parties' Motions Shot Down In Ethyol Patent Suit

Law360, New York (April 1, 2009, 12:00 AM EDT) -- In MedImmune Oncology Inc.'s protracted patent spat against Sun Pharmaceutical Industries Ltd. over the cancer therapy drug Ethyol, a federal judge has denied MedImmune's motion for partial summary judgment as to several of Sun's defenses, as well as Sun's motion for summary judgment that the remaining patent-in-suit is invalid.

Judge Marvin J. Garbis of the U.S. District Court for the District of Maryland on Tuesday handed down an order denying MedImmune's motion for summary judgment on Sun's anticipation defense, its inequitable conduct defense based on work...
To view the full article, register now.